BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221109
DTEND;VALUE=DATE:20221112
DTSTAMP:20260516T041217
CREATED:20220728T083732Z
LAST-MODIFIED:20220728T083732Z
UID:34796-1667952000-1668211199@www.pharmajournalist.com
SUMMARY:6th Antifibrotic Drug Development Summit (AFDD)
DESCRIPTION:Returning for the 6th year\, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF\, NASH\, CKD and more in one place at one time\, so you can advance the progress of your antifibrotic therapies. \nFrom exploring cellular mechanisms to identify a common fibrotic pathway to bridging the translational gap to prove early therapeutic effectiveness; this unique cross-organ\, cross-disease\, cross-discipline discussion forum is here to transform your fibrosis research. \nJoin 100+ industry super giants from Boehringer Ingelheim\, Genentech\, Gilead\, Pfizer\, Novartis\, and many more in Boston to harness the knowledge you need for your 2022/23 antifibrotic research and drug development. \nTo know more visit: https://ter.li/u60ni5
URL:https://www.pharmajournalist.com/event/6th-antifibrotic-drug-development-summit-afdd/
LOCATION:Crowne Plaza Woburn\, 15 Middlesex Canal Park Rd\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR